U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT06832631) titled 'VITUS Post-Market Registry' on Feb. 12.
Brief Summary: To collect post marketing surveillance data on consecutive patients with peripheral arterial occlusive disease (PAOD) intended to be or treated by the VITUS peripheral drug-coated dilatation catheter when used according to the Instructions for Use and treating physician decision. Data will be collected in order to assess the long-term safety and performance of the VITUS peripheral drug-coated dilatation catheter in routine clinical practice.
Study Start Date: April, 2025
Study Type: OBSERVATIONAL
Condition:
Peripheral Arterial Disease
Peripheral Arterial Occlusive Disease
I...